Macopharma SA Competitors or Alternatives

Macopharma SA's top competitors include Haemonetics, Terumo BCT and Fresenius.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Macopharma SA's company profile

Ronald De Lagrange

President & CEO

75/100
1,000 - 5,000
$0
$500M - 1B
1
Macopharma SA's Competitor - Haemonetics logo

Christopher Simon

President & CEO

96/100
2,820
- -
$1.4B
2
Macopharma SA's Competitor - Terumo BCT logo

Antoinette Gawin

President & CEO

69/100
5,000 - 10,000
$17.4M
$500M - 1B
3
Macopharma SA's Competitor - Fresenius logo

Michael Sen

CEO

88/100
175,771
$2.6B
$14.2B
4
Macopharma SA's Competitor - Baxter logo

Brent Shafer

Interim-CEO

- -
60,000
$2.5B
$10.6B
5
Macopharma SA's Competitor - B. Braun logo

CEO

- -
50,000 - 100,000
- -
$5B - 10B

Macopharma SA VS Haemonetics

Haemonetics is one of Macopharma SA's top competitors. Haemonetics was founded in 1953, and its headquarters is in Boston, Massachusetts. Like Macopharma SA, Haemonetics also works within the Pharmaceuticals & Biotechnology sector. Haemonetics has 620 more employees than Macopharma SA.

Macopharma SA VS Terumo BCT

Terumo BCT is Macopharma SA's #2 rival. Terumo BCT was founded in 1964 in Lakewood, Colorado. Terumo BCT operates in the Biotechnology industry. Terumo BCT generates $381M more revenue than Macopharma SA.

Macopharma SA VS Fresenius

Fresenius is a top competitor of Macopharma SA. Fresenius is a Public company that was founded in Bad Homburg, Hesse in 1912. Fresenius is in the Health Care Services field. Fresenius has 173,571 more employees vs. Macopharma SA.

Frequently Asked Questions about Macopharma SA

  1. Who are Macopharma SA's top competitors?

    Macopharma SA's top 3 competitors are Haemonetics, Terumo BCT, Fresenius.
  2. Who is similar to Macopharma SA?

    Haemonetics is the most similar to Macopharma SA. Terumo BCT and Fresenius are also similar to Macopharma SA.
  1. Are Macopharma SA and Haemonetics competitors?

    Yes, Haemonetics is one of Macopharma SA’s top competitors.